Within the FTD subtypes, there was a tendency for groups with probable TDP-43 pathology (svPPA and FTD-MND clinically, GRN and C9orf72 mutations genetically) to have raised levels compared with those associated with tau pathology (MAPT mutations), although within all groups there is substantial variability. The gene discussed is TARDBP; the disease is mild neurocognitive disorder.